4.7 Article

An active IGF-1R-AKT signaling imparts functional heterogeneity in ovarian CSC population

Journal

SCIENTIFIC REPORTS
Volume 6, Issue -, Pages -

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/srep36612

Keywords

-

Funding

  1. UGC
  2. ACTREC
  3. TMC-IRG

Ask authors/readers for more resources

Deregulated IGF-1R-AKT signaling influences multiple nodes of cancer cell physiology and assists in migration, metastasis and acquirement of radio/chemoresistance. Enrichment of cancer stem cells (CSC) positively correlates with radio/chemoresistance development in various malignancies. It is unclear though, how IGF-1R-AKT signalling shapes CSC functionality especially in ovarian cancer. Previously we showed that upregulated IGF-1R expression is essential to initiate platinum-taxol resistance at early stage which declines with elevated levels of activated AKT at late resistant stage in ovarian cancer cells. Here, we investigated the effect of this oscillatory IGF-1R-AKT signalling upon CSC functionality during generation of chemoresistance. While gradual increase in CSC properties from early (ER) to late (LR) resistant stages was observed in three different (cisplatin/paclitaxel/cisplatin-paclitaxel) cellular models created in two ovarian cancer cell lines, the stemness gene expressions (oct4/sox2/nanog) reached a plateau at early resistant stages. Inhibition of IGF-1R only at ER and AKT inhibition only at LR stages significantly abrogated the CSC phenotype. Interestingly, real time bioluminescence imaging showed CSCs of ER stages possessed faster tumorigenic potential than CSCs belonging to LR stages. Together, our data suggest that IGF-1R-AKT signalling imparts functional heterogeneity in CSCs during acquirement of chemoresistance in ovarian carcinoma.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Biochemistry & Molecular Biology

Decoding molecular interplay between RUNX1 and FOXO3a underlying the pulsatile IGF1R expression during acquirement of chemoresistance

Ajit C. Dhadve, Kishore Hari, Bharat Rekhi, Mohit Kumar Jolly, Abhijit De, Pritha Ray

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2020)

Article Cell Biology

EpCAM-Mediated Cellular Plasticity Promotes Radiation Resistance and Metastasis in Breast Cancer

Arijit Mal, Amirali B. Bukhari, Ram K. Singh, Aastha Kapoor, Amlan Barai, Ishan Deshpande, Tabassum Wadasadawala, Pritha Ray, Shamik Sen, Abhijit De

Summary: A substantial number of breast cancer patients undergoing radiation therapy develop local recurrence over time, suggesting adaptive radioresistance. This study established radioresistant cell lines and found that EpCAM overexpression in CSCs contributes to radioresistance and metastatic behavior. EpCAM-overexpressing cells exhibit plasticity and heterogeneity, ultimately aggravating the disease condition by inducing radioresistant and metastatic behavior.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)

Article Pharmacology & Pharmacy

pH-responsive delivery of anti-metastatic niclosamide using mussel inspired polydopamine nanoparticles

Omkar Mhatre, B. Pradeep K. Reddy, Chetna Patnaik, Sabyasachi Chakrabarty, Aravind Ingle, Abhijit De, Rohit Srivastava

Summary: Niclosamide, an FDA approved antihelminthic drug, is now being repurposed as a potent anti-cancer and anti-inflammatory agent through encapsulation in polydopamine nanoparticles. The nanoparticles exhibit high drug loading efficiency, pH-dependent drug release profile, and time-dependent cellular uptake with significant cytotoxicity in cancer cells. Furthermore, the nanoparticles show excellent in vivo compatibility and non-toxic nature, demonstrating their potential for clinical application.

INTERNATIONAL JOURNAL OF PHARMACEUTICS (2021)

Article Pharmacology & Pharmacy

Intravitreal galactose conjugated polymeric nanoparticles of etoposide for retinoblastoma

Rutika Godse, Maitreyi Rathod, Abhijit De, Ujwala Shinde

Summary: This study developed a novel sugar receptor-targeted drug delivery system for retinoblastoma cells using etoposide as a model drug. The system showed high specificity and cytotoxicity, demonstrating potential as a new therapeutic approach for retinoblastoma.

JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY (2021)

Article Pharmacology & Pharmacy

Smart releasing CuS/ZnS nanocomposite dual drug carrier and photothermal agent for use as a theranostic tool for cancer therapy

Aishwarya Shetty, Sumit K. Mishra, Abhijit De, Sudeshna Chandra

Summary: This study reports the synthesis of a multifunctional nanocomposite for targeted cancer therapy. The nanocomposite exhibits near-infrared light responsive photothermal therapy and potential for photoluminescence. Both in vitro and in vivo experiments demonstrate the promising application of this nanocomposite in cancer treatment.

JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY (2022)

Article Oncology

Direct knockdown of phospho-PTM targets mediated by TRIM21 can improve personalized treatment in breast cancer

Pranay Dey, Mansi Joshi, Aaiyas Mujawar, Renu Malhotra, Abhijit De

Summary: In this study, we demonstrated for the first time the specific and direct knockdown of important oncogenic proteins and their phospho-PTM targets using a method called 'TRIM-ing' in TRIM21 overexpressing breast cancer cells. The results showed rapid degradation of the target proteins, disrupting downstream signaling and providing significant therapeutic effects.

CELLULAR ONCOLOGY (2022)

Article Biochemistry & Molecular Biology

Pathogenic HER3 dimerization domain mutations create a structural bias towards un-conventional EGFR-HER3 signalling axis in breast cancer

Pranay Dey, Nikhil Gadewal, Abhijit De

Summary: Among the EGFR family, HER3 acts as a pseudo-kinase and primarily interacts with HER2 in the presence of heregulin-1 beta. The hotspot mutations G284R and D297Y, as well as the double mutant HER2-S310F/HER3-G284R, were identified in breast cancer patients. These mutations cause conformational changes in the flanking regions of HER2, resulting in an unstable heterodimer and abrogating downstream signalling. The HER3-D297Y mutation forms stable interactions with EGFR-WT in the presence of EGF or heregulin-1 beta, making cancer cells susceptible to EGFR-targeted drugs.

INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2023)

Article Chemistry, Analytical

Triple Reporter Assay: A Non-Overlapping Luciferase Assay for the Measurement of Complex Macromolecular Regulation in Cancer Cells Using a New Mushroom Luciferase-Luciferin Pair

Aaiyas Mujawar, Pratham Phadte, Ksenia A. Palkina, Nadezhda M. Markina, Ameena Mohammad, Bhushan L. Thakur, Karen S. Sarkisyan, Anastasia V. Balakireva, Pritha Ray, Ilia Yamplosky, Abhijit De

Summary: This study presents the development of a humanized luciferase imaging reporter based on a mushroom luciferase called Luz. In vitro and in vivo assessments demonstrate that the human-codon-optimized Luz has higher activity than native Luz in cancer cell types. The importance of live cell multiplexed measurement of gene regulatory function using more than two luciferases is suggested to address realistic situations in disease biology.

SENSORS (2023)

Article Materials Science, Multidisciplinary

The Multifaceted Role of Degradable Cobalt Nanoparticles: Dual-Target Starvation and Intracellular Acidification Engendering LC3-Associated Whole-Cell Autophagy

Gayathri Ravichandran, Dinesh Harijan, Nagarajan Ganapathy, Ganesan Prabusankar, Abhijit De, Aravind Kumar Rengan

Summary: In this study, we have uncovered the potential therapeutic role of cobalt nanoparticles by elucidating their interaction with oxygen and amino acids. This discovery has led to the design of a novel combinatorial targeted therapy that induces cell death through starvation and acidification, as well as the identification of autophagy and cellular degradation.

ACS MATERIALS LETTERS (2023)

Article Nanoscience & Nanotechnology

Multimodal Applications of Zinc Gallate-Based Persistent Luminescent Nanoparticles in Cancer Treatment: Tumor Margining, Diagnosis, and Boron Neutron Capture Therapy

K. Shitaljit Sharma, M. Swathi Raju, Suhas Phapale, Snehal K. Valvi, Akhil K. Dubey, Dibakar Goswami, Debes Ray, Abhijit De, Prasad P. Phadnis, Vinod K. Aswal, Rajesh Vatsa, Haladhar D. Sarma

Summary: Based on boron neutron capture therapy (BNCT), researchers have developed a zinc gallate-based nanoformulation for cancer treatment and diagnosis. The nanoformulation, with its functionalized surface, effectively targets tumor cells and demonstrates excellent therapeutic efficacy in in vitro and in vivo studies.

ACS APPLIED BIO MATERIALS (2022)

Article Nanoscience & Nanotechnology

pH-(Low)-Insertion Peptide-Assisted Detection and Diagnosis of Cancer Using Zinc Gallate-Based Persistent Luminescence Nanoparticles

K. Shitaljit Sharma, Swathi M. Raju, Dibakar Goswami, Abhijit De, Prasad P. Phadnis, Rajesh K. Vatsa

Summary: In this study, zinc gallate-based persistent luminescence nanoparticles coated with a variant of pH-low-insertion peptide (pHLIP) were developed for cancer detection and diagnosis. Results indicated that these nanoparticles exhibited faster and more precise uptake in the acidic tumor environment compared to other organs. Experiments on mice showed successful tumor targeting within a short period of time.

ACS APPLIED BIO MATERIALS (2021)

Article Nanoscience & Nanotechnology

Characteristics of Molecularly Engineered Anticancer Drug Conjugated Organic Nanomicelles for Site-Selective Cancer Cell Rupture and Growth Inhibition of Tumor Spheroids

Nishant Kumar Jain, Shalini Dimri, Rajendra Prasad, Gayathri Ravichandran, Vegi Naidu, Abhijit De, Rohit Srivastava

ACS APPLIED BIO MATERIALS (2020)

Article Nanoscience & Nanotechnology

BF2-Oxasmaragdyrin Nanoparticles: A Non-toxic, Photostable, Enhanced Non-radiative Decay-Assisted Efficient Photothermal Cancer Theragnostic Agent

Kandala Laxman, B. Pradeep K. Reddy, Sumit K. Mishra, Maddala Bala Gopal, Andrea Robinson, Abhijit De, Rohit Srivastava, Mangalampalli Ravikanth

ACS APPLIED MATERIALS & INTERFACES (2020)

Article Nanoscience & Nanotechnology

Noninvasive Preclinical Evaluation of Targeted Nanoparticles for the Delivery of Curcumin in Treating Pancreatic Cancer

R. S. Prabhuraj, Arijit Mal, Snehal K. Valvi, Rohit Srivastava, Abhijit De, Rajdip Bandyopadhyaya

ACS APPLIED BIO MATERIALS (2020)

Article Oncology

Noncanonical pS727 post translational modification dictates major STAT3 activation and downstream functions in breast cancer

Shalini Dimri, Renu Malhotra, Tanuja Shet, Smruti Mokal, Sudeep Gupta, Abhijit De

EXPERIMENTAL CELL RESEARCH (2020)

No Data Available